The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.14
Bid: 0.13
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.02 (15.385%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.14
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in 1911 Gold Corporation

28 Dec 2023 07:00

RNS Number : 9838X
Gunsynd PLC
28 December 2023
 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

Investment in 1911 Gold Corporation

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce that it has invested approximately CAD$350,000 (c. £200,000) (the "Investment") into 1911 Gold Corporation (TSXV: AUMB) ("1911 Gold"), a junior gold development and exploration company located in Manitoba, in the heart of the Rice Lake gold district within the West Uchi greenstone belt in Canada.

 

The Investment was executed on the following terms:

 

· subscription for 5,833,333 ordinary shares at CAD$0.06 per share for total consideration of approximately £200,000 from the Company's existing cash resources.

 

· For each ordinary share subscribed for in 1911 Gold, the Company has received a warrant over a new ordinary share with an exercise price of CAD$ 0.10 per share and exercisable for a period of 24 months from the date of closing of the offering by 1911 Gold.

 

· The Investment by the Company is part of the CAD$ 3.9 million private placement ("Offering") recently announced by 1911 Gold. The financing received a lead order from renowned precious metals investor Mr Eric Sprott.

 

· Following the Investment Gunsynd will have approximately a 4.3% interest in 1911 Gold

 

About 1911 Gold:

1911 Gold is a junior explorer that holds a highly prospective, consolidated land package totalling more than 63,000 hectares within and adjacent to the Archean Rice Lake greenstone belt in Manitoba, and also owns the True North mine and mill complex (Fully Permitted) at Bissett, Manitoba.

 

1911 Gold believes its land package is a prime exploration opportunity, with potential to develop a mining district centred on the True North complex. The True North Mine has an existing NI 43-101 (2018) resource of 1m ounces at 6.4g/t ("Resource Report").

 

The company also owns the Apex project near Snow Lake, Manitoba and the Denton-Keefer project near Timmins, Ontario, and intends to focus on organic growth and accretive acquisition opportunities in North America.

 

Gary O'Connor, former President and Chief Executive Officer ("CEO") of Moneta Gold Inc. and an experienced geologist with over 35 years in the industry, has joined 1911 Gold as a key technical advisor to assist in executing this strategy.

 

The gross proceeds raised from the Offering will be used by 1911 Gold as follows:

 

· The proceeds are to be used to fund exploration programs at 1911 Gold's flagship Rice Lake property in Manitoba, focusing on near-mine target areas.

· The proceeds are also expected to be used to fund the review and optimisation of the Resource Report as well as for general corporate purposes.

 

For the year ended 31 December 2022, 1911 Gold had revenue of CAD$ 5,884,000 and made a loss of CAD$ 11,387,000.

 

 

Peter Ruse, a director of Gunsynd, commented: "It very exciting to have secured a position in a gold development and exploration opportunity such as 1911. Its not often you can invest into a company that owns a mill and mining complex, 1m ounces at an attractive grade of 6.4g/t and a vast portfolio of exploration tenure along strike in a first world mining jurisdiction all for a very modest market cap of CAD $5m. Gunsynd was very pleased to be investing alongside well renowned gold investor Eric Sprott who corner stoned the CAD $3.9m fundraise. This only strengthens our confidence of the potential upside and value creation amongst a backdrop of record Gold prices"

 

For more information on 1911, shareholders are encouraged to visit their website: www.1911gold.com

 

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDBBDDSXDDGXR
Date   Source Headline
6th Dec 20129:57 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20127:00 amRNSApproval of Opening Position Disclosure
5th Dec 201211:11 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 201211:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Dec 201212:19 pmRNSForm 8.3 - [Evocutis PLC]
3rd Dec 20127:00 amRNSStrategic Review
3rd Dec 20127:00 amRNSFinal Results
23rd Nov 20127:00 amRNSNotice of Results
5th Nov 20127:00 amRNSIssue of Equity
21st Sep 20127:00 amRNSTR-1 Notification of Major Interest in Shares
8th Aug 201212:24 pmRNSUpdate on commencement of dealings
1st Aug 20127:00 amRNSIssue of Equity and Grant of Share Options
21st Jun 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectorate Change
4th Apr 20127:00 amRNSDirectorate Change
22nd Mar 20127:00 amRNSInterim Results
29th Feb 20127:00 amRNSNotification of Results
27th Jan 20127:00 amRNSEvocutis validates anti-ageing LabSkinT model
24th Jan 20121:35 pmRNSResult of AGM
13th Jan 20127:00 amRNSEvocutis Opens State-of-the-art laboratory
23rd Dec 20117:00 amRNSDirector/PDMR Shareholding
15th Dec 20117:00 amRNSNotice of AGM and Report and Accounts
29th Nov 20117:00 amRNSPreliminary Results
28th Nov 20117:00 amRNSEvocutis launches antimicrobial LabSkinT model
20th Oct 20115:03 pmRNSResult of GM and Change of Name to Evocutis plc
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.